ORKA SCHEDULE 13G/A: SEC filing

An institutional holder

Filed with the SEC on · accession 0001231919-26-000934

ORKA filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 14, 2026. A report the company filed with the SEC (the US market regulator). The stock moved +2.7% by the first close after the filing.

Summary of the filing

An institutional holder filed an amended Schedule 13G indicating a change in its passive ownership position in Oruka Therapeutics, Inc. The filing does not disclose a control intent or activist campaign.

Key details

IssuerOruka Therapeutics, Inc.

How ORKA stock reacted

Close before

$108.12

Aug 13, 2026

First close after

+2.70%

$111.04

5 trading days

-3.02%

$104.86

Since filing

-4.86%

$102.86

✦ Ask GOAX AI about this filing — what it means for ORKA, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ORKA?

Click here

Frequently asked questions

What did ORKA file with the SEC on Aug 14, 2026?

ORKA filed a SCHEDULE 13G/A (SEC filing). An institutional holder filed an amended Schedule 13G indicating a change in its passive ownership position in Oruka Therapeutics, Inc. The filing does not disclose a control intent or activist campaign.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did ORKA stock react to this filing?

ORKA closed at $108.12 before the filing and $111.04 on Aug 14, 2026 (+2.70%). Five trading days later: $104.86 (-3.02%).

Other ORKA SEC filings

Get alerts when ORKA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days